GENE ONLINE|News &
China’s Pharma Industry is Booming with Talents and Startups. What Makes All the Rage?
China’s pharmaceutical market has become a global hotspot for investment in recent years. The diverse array of patients and increasing medical needs attract overseas companies, and China has also been sharpening local R&D power to compete with the global market.
GeneOnline attempts to look into the fast-paced market and analyzes China’s biopharma trends and development.
GO Prime with only $1.49 now
LATEST
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
